MDR1 expression identifies human melanoma stem cells

被引:86
|
作者
Keshet, Gilmor I. [1 ]
Goldstein, Itarnar [1 ]
Itzhaki, Orit [2 ]
Cesarkas, Karen [1 ]
Shenhav, Liraz [1 ]
Yakirevitch, Arkadi [2 ]
Treves, Avraham J. [2 ]
Schachter, Jacob [2 ]
Amariglio, Ninette [1 ]
Rechavi, Gideon [1 ]
机构
[1] Tel Aviv Univ, Canc Res Ctr, Tel Hashomer & Sackler Sch Med, Sheba Med Ctr, IL-52621 Tel Aviv, Israel
[2] Tel Aviv Univ, Ella Inst Melanoma Res & Treatment, Tel Hashomer & Sackler Sch Med, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
关键词
multidrug resistance; melanoma; cancer stem cells; self-renewal; anchorage independence;
D O I
10.1016/j.bbrc.2008.02.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ABC transporters are often found to be inherently expressed in a wide variety of stem cells, where they provide improved protection from toxins. We found a subpopulation of human melanoma cells expressing multidrug-resistance gene product 1 (MDR1). This fraction co-expresses the ABC transporters, ABCB5 and ABCC2 in addition to the stem cell markers, nanog and human telomerase reverse transcriptase (hTERT). The clonogenicity and self-renewal capacity of MDR1(+) melanoma cells were investigated in single cell settings using the limiting dilution assay. We found that the MDR1(+) cells, isolated by FACS sorting, demonstrated a higher self-renewal capacity than the MDR1(-) fraction, a key stem cell feature. Moreover, MDR1(+) cells had higher ability to form spheres in low attachment conditions, a hallmark of cancer. In conclusion, these novel findings imply that the MDR1(+) cells represent melanoma stem cells and thus should be considered as a unique cellular target for future anti-melanoma therapies. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:930 / 936
页数:7
相关论文
共 50 条
  • [41] MULTIDRUG RESISTANCE GENE (MDR1) EXPRESSION IN HUMAN BRAIN-TUMORS
    NABORS, MW
    GRIFFIN, CA
    ZEHNBAUER, BA
    HRUBAN, RH
    PHILLIPS, PC
    GROSSMAN, SA
    BREM, H
    COLVIN, OM
    JOURNAL OF NEUROSURGERY, 1991, 75 (06) : 941 - 946
  • [42] Drug resistance and MDR1 gene expression of AML blast cells.
    Norgaard, JM
    Bukh, A
    Palshof, T
    Hokland, P
    BLOOD, 1997, 90 (10) : 3649 - 3649
  • [43] Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma
    Schneider, J
    Centeno, M
    Jimenez, E
    RodriguezEscudero, FJ
    Romero, H
    ANTICANCER RESEARCH, 1997, 17 (3C) : 2147 - 2151
  • [44] MDR1 EXPRESSION IN HUMAN LEUKEMIA-LYMPHOMA CELL-LINES
    METGE, K
    STEUBE, K
    UPHOFF, CC
    GIGNAC, SM
    DREXLER, HG
    LEUKEMIA, 1993, 7 (06) : 896 - 897
  • [45] MULTIDRUG-RESISTANCE GENE (MDR1) EXPRESSION IN HUMAN TUMOR XENOGRAFTS
    ABE, Y
    NAKAMURA, M
    OHNISHI, Y
    INABA, M
    UEYAMA, Y
    TAMAOKA, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (06) : 1285 - 1292
  • [46] Induction of MDR1 expression in normal rat and human intestine in vivo.
    Lown, KS
    Kolars, JC
    Ghosh, M
    SchmiedlinRen, P
    Watkins, PB
    GASTROENTEROLOGY, 1996, 110 (04) : A344 - A344
  • [47] Expression of the MDR1 (P-glycoprotein) gene in human prostate tissue
    Siegsmund, M
    Schummer, B
    Steidler, A
    Kreukler, C
    Greschner, M
    Kohrmann, KU
    Alken, P
    AKTUELLE UROLOGIE, 1997, 28 (04) : 202 - 206
  • [48] Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells
    Batetta, B
    Mulas, MF
    Petruzzo, P
    Putzolu, M
    Bonatesta, RR
    Sanna, F
    Cappai, A
    Brotzu, G
    Dessì, S
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (08) : 1113 - 1120
  • [49] The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts
    Boven, E
    Jansen, WJM
    Hulscher, TM
    Beijnen, JH
    van Tellingen, O
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (05) : 840 - 849
  • [50] Tissue mRNA expression of monkey MDR1 and functional analysis of monkey MDR1/P-glycoprotein
    Adachi, Y
    Mulhern, D
    Ninomiya, S
    Sudo, T
    DRUG METABOLISM REVIEWS, 2004, 36 : 55 - 55